Oramed Patent Allowed in the U.S. for Key Aspect of Its Oral Delivery Technology

NEW YORK: Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that its U.S
error: Content is protected !!